Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Non-Drug-Eluting Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4661995
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 115 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Non-Drug-Eluting Devices market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Non-drug eluting devices perform specific functions without releasing drugs. They are used in medical procedures and treatments, focusing on physical or mechanical interventions. Implants typically need removal, while sutures dissolve naturally and do not require removal. Key properties of these devices include primarily providing structural support, being made from biocompatible materials, maintaining sterility to prevent infections, offering high durability and strength, and performing specific functions. Long-term use of drugs to treat cardiovascular diseases may cause some side effects, such as bleeding, liver and kidney damage, etc. Non-drug eluting devices can reduce the amount of drugs used to a certain extent, thereby reducing the risk of drug side effects. With the continuous advancement of medical imaging technology and interventional treatment technology, the treatment of non-drug eluting devices will be more accurate. Doctors can use high-resolution imaging equipment to accurately locate the lesion and select appropriate treatment methods and equipment to improve the treatment effect.
This report is a detailed and comprehensive analysis for global Non-Drug-Eluting Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Drug-Eluting Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Non-Drug-Eluting Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Non-Drug-Eluting Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Non-Drug-Eluting Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Drug-Eluting Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Drug-Eluting Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Medtronic, B. Braun Melsungen AG, Boston Scientific Corporation, ConMed Corporation, DemeTECH Corporation, Integra Lifesciences, Johnson & Johnson, Peter Surgical, Smith & Nephew plc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-Drug-Eluting Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Implants
Sutures
Market segment by Application
Hospital
Ambulatory Surgical Centers
Major players covered
Stryker Corporation
Medtronic
B. Braun Melsungen AG
Boston Scientific Corporation
ConMed Corporation
DemeTECH Corporation
Integra Lifesciences
Johnson & Johnson
Peter Surgical
Smith & Nephew plc.
Teleflex Incorporated
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Drug-Eluting Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Drug-Eluting Devices, with price, sales quantity, revenue, and global market share of Non-Drug-Eluting Devices from 2020 to 2025.
Chapter 3, the Non-Drug-Eluting Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Non-Drug-Eluting Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Drug-Eluting Devices.
Chapter 14 and 15, to describe Non-Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Non-Drug-Eluting Devices Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Implants
    • 1.3.3 Sutures
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Non-Drug-Eluting Devices Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Ambulatory Surgical Centers
  • 1.5 Global Non-Drug-Eluting Devices Market Size & Forecast
    • 1.5.1 Global Non-Drug-Eluting Devices Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Non-Drug-Eluting Devices Sales Quantity (2020-2031)
    • 1.5.3 Global Non-Drug-Eluting Devices Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Stryker Corporation
    • 2.1.1 Stryker Corporation Details
    • 2.1.2 Stryker Corporation Major Business
    • 2.1.3 Stryker Corporation Non-Drug-Eluting Devices Product and Services
    • 2.1.4 Stryker Corporation Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Stryker Corporation Recent Developments/Updates
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Non-Drug-Eluting Devices Product and Services
    • 2.2.4 Medtronic Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medtronic Recent Developments/Updates
  • 2.3 B. Braun Melsungen AG
    • 2.3.1 B. Braun Melsungen AG Details
    • 2.3.2 B. Braun Melsungen AG Major Business
    • 2.3.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Product and Services
    • 2.3.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 B. Braun Melsungen AG Recent Developments/Updates
  • 2.4 Boston Scientific Corporation
    • 2.4.1 Boston Scientific Corporation Details
    • 2.4.2 Boston Scientific Corporation Major Business
    • 2.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Product and Services
    • 2.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Boston Scientific Corporation Recent Developments/Updates
  • 2.5 ConMed Corporation
    • 2.5.1 ConMed Corporation Details
    • 2.5.2 ConMed Corporation Major Business
    • 2.5.3 ConMed Corporation Non-Drug-Eluting Devices Product and Services
    • 2.5.4 ConMed Corporation Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 ConMed Corporation Recent Developments/Updates
  • 2.6 DemeTECH Corporation
    • 2.6.1 DemeTECH Corporation Details
    • 2.6.2 DemeTECH Corporation Major Business
    • 2.6.3 DemeTECH Corporation Non-Drug-Eluting Devices Product and Services
    • 2.6.4 DemeTECH Corporation Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 DemeTECH Corporation Recent Developments/Updates
  • 2.7 Integra Lifesciences
    • 2.7.1 Integra Lifesciences Details
    • 2.7.2 Integra Lifesciences Major Business
    • 2.7.3 Integra Lifesciences Non-Drug-Eluting Devices Product and Services
    • 2.7.4 Integra Lifesciences Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Integra Lifesciences Recent Developments/Updates
  • 2.8 Johnson & Johnson
    • 2.8.1 Johnson & Johnson Details
    • 2.8.2 Johnson & Johnson Major Business
    • 2.8.3 Johnson & Johnson Non-Drug-Eluting Devices Product and Services
    • 2.8.4 Johnson & Johnson Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Johnson & Johnson Recent Developments/Updates
  • 2.9 Peter Surgical
    • 2.9.1 Peter Surgical Details
    • 2.9.2 Peter Surgical Major Business
    • 2.9.3 Peter Surgical Non-Drug-Eluting Devices Product and Services
    • 2.9.4 Peter Surgical Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Peter Surgical Recent Developments/Updates
  • 2.10 Smith & Nephew plc.
    • 2.10.1 Smith & Nephew plc. Details
    • 2.10.2 Smith & Nephew plc. Major Business
    • 2.10.3 Smith & Nephew plc. Non-Drug-Eluting Devices Product and Services
    • 2.10.4 Smith & Nephew plc. Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Smith & Nephew plc. Recent Developments/Updates
  • 2.11 Teleflex Incorporated
    • 2.11.1 Teleflex Incorporated Details
    • 2.11.2 Teleflex Incorporated Major Business
    • 2.11.3 Teleflex Incorporated Non-Drug-Eluting Devices Product and Services
    • 2.11.4 Teleflex Incorporated Non-Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Teleflex Incorporated Recent Developments/Updates

3 Competitive Environment: Non-Drug-Eluting Devices by Manufacturer

  • 3.1 Global Non-Drug-Eluting Devices Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Non-Drug-Eluting Devices Revenue by Manufacturer (2020-2025)
  • 3.3 Global Non-Drug-Eluting Devices Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Non-Drug-Eluting Devices by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Non-Drug-Eluting Devices Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Non-Drug-Eluting Devices Manufacturer Market Share in 2024
  • 3.5 Non-Drug-Eluting Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Non-Drug-Eluting Devices Market: Region Footprint
    • 3.5.2 Non-Drug-Eluting Devices Market: Company Product Type Footprint
    • 3.5.3 Non-Drug-Eluting Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Non-Drug-Eluting Devices Market Size by Region
    • 4.1.1 Global Non-Drug-Eluting Devices Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Non-Drug-Eluting Devices Consumption Value by Region (2020-2031)
    • 4.1.3 Global Non-Drug-Eluting Devices Average Price by Region (2020-2031)
  • 4.2 North America Non-Drug-Eluting Devices Consumption Value (2020-2031)
  • 4.3 Europe Non-Drug-Eluting Devices Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Non-Drug-Eluting Devices Consumption Value (2020-2031)
  • 4.5 South America Non-Drug-Eluting Devices Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Non-Drug-Eluting Devices Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Non-Drug-Eluting Devices Sales Quantity by Type (2020-2031)
  • 5.2 Global Non-Drug-Eluting Devices Consumption Value by Type (2020-2031)
  • 5.3 Global Non-Drug-Eluting Devices Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Non-Drug-Eluting Devices Sales Quantity by Application (2020-2031)
  • 6.2 Global Non-Drug-Eluting Devices Consumption Value by Application (2020-2031)
  • 6.3 Global Non-Drug-Eluting Devices Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Non-Drug-Eluting Devices Sales Quantity by Type (2020-2031)
  • 7.2 North America Non-Drug-Eluting Devices Sales Quantity by Application (2020-2031)
  • 7.3 North America Non-Drug-Eluting Devices Market Size by Country
    • 7.3.1 North America Non-Drug-Eluting Devices Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Non-Drug-Eluting Devices Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Non-Drug-Eluting Devices Sales Quantity by Type (2020-2031)
  • 8.2 Europe Non-Drug-Eluting Devices Sales Quantity by Application (2020-2031)
  • 8.3 Europe Non-Drug-Eluting Devices Market Size by Country
    • 8.3.1 Europe Non-Drug-Eluting Devices Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Non-Drug-Eluting Devices Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Non-Drug-Eluting Devices Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Non-Drug-Eluting Devices Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Non-Drug-Eluting Devices Market Size by Region
    • 9.3.1 Asia-Pacific Non-Drug-Eluting Devices Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Non-Drug-Eluting Devices Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Non-Drug-Eluting Devices Sales Quantity by Type (2020-2031)
  • 10.2 South America Non-Drug-Eluting Devices Sales Quantity by Application (2020-2031)
  • 10.3 South America Non-Drug-Eluting Devices Market Size by Country
    • 10.3.1 South America Non-Drug-Eluting Devices Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Non-Drug-Eluting Devices Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Non-Drug-Eluting Devices Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Non-Drug-Eluting Devices Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Non-Drug-Eluting Devices Market Size by Country
    • 11.3.1 Middle East & Africa Non-Drug-Eluting Devices Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Non-Drug-Eluting Devices Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Non-Drug-Eluting Devices Market Drivers
  • 12.2 Non-Drug-Eluting Devices Market Restraints
  • 12.3 Non-Drug-Eluting Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Non-Drug-Eluting Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Non-Drug-Eluting Devices
  • 13.3 Non-Drug-Eluting Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Non-Drug-Eluting Devices Typical Distributors
  • 14.3 Non-Drug-Eluting Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Non-Drug-Eluting Devices. Industry analysis & Market Report on Non-Drug-Eluting Devices is a syndicated market report, published as Global Non-Drug-Eluting Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Non-Drug-Eluting Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo